Recent additions to Life Sciences Notes

Recent additions to our Life Sciences Notes blog include a podcast featuring Veronica Roberts – who leads our global foreign direct investment group and was closely involved in the introduction of the UK’s National Security and Investment (NSI) regime – on the impact of the regime on deals in the pharmaceuticals and healthcare sector, focusing … Read more

The UK National Security and Investment regime: spotlight on pharma M&A

In this fourth episode in the FDI Friday series Bob Moore (Partner), Veronica Roberts (Partner), and Ruth Allen (Professional Support Lawyer) discuss practical insights into the application of the UK’s National Security and Investment (NSI) regime to deals in the pharma sector, drawing on their experience of regularly dealing with the Investment Security Unit (ISU) … Read more

Navigating Contract Research Organisation Agreements: A legal perspective

The role of a Contract Research Organisation (“CRO“) has become increasingly significant in the life sciences industry, providing invaluable support to clinical trial sponsors. In recent years, a trend towards CRO consolidation has been observed, driven by greater access to capital and strategic acquisitions. The legal landscape surrounding CRO agreements has become increasingly complex as … Read more

HSF comments to JUVE Patent on expectations and aspirations for the UPC

On 1 June 2023, the Unified Patent Court (UPC) and unitary patent (UP) system finally launched, bringing with it fundamental changes to the patent landscape across Europe. Laura Orlando, Milan Partner and Joint Global Head of Intellectual Property at Herbert Smith Freehills, was recently interviewed by Amy Sandys at JUVE Patent, alongside other private practice … Read more

The Unified Patent Court (UPC) starts today – 1 June 2023

Today marks the launch of the new Unified Patent Court (UPC) and unitary patent (UP) system in Europe – the culmination of decades of work, bringing with it fundamental changes to the way in which patents can be litigated in Europe. Find out more about the UPC, the unitary patent, and how our fully integrated … Read more

UPC central division cases that would have gone to the London seat under original UPC plans will be split between Paris and Munich seats initially

The UPC has announced that the UPC Presidium has exercised its managerial power to decide that matters before the UPC that would have fallen under the patent classifications (A and C) that would have originally gone to London until the UK withdrew from the UPC Agreement, will be shared between Paris and Munich initially, as of the UPC start date of 1 June 2023, until such time as a decision has been made on the third seat. Read more

Webinar recording: The UPC countdown has started – are you ready?

On 29 March, our leading lawyers in Düsseldorf, Milan, Paris and London hosted a webinar exploring what businesses need to know and what they need to be doing now to prepare for the Unified Patent Court (UPC), which is set to start hearing cases on 1 June 2023. The presentation was followed by a short … Read more